Clinical Trial Update: A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing Hemopure to improve tissue preservation during cardiopulmonary bypass surgery in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Hemopure (HBOC-201)

Snippet

Sponsor: Biopure Corporation | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN